Percheron Therapeutics Ltd
PER
Company Profile
Business description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Contact
Sector
Healthcare
Stock type
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,466.10 | 31.90 | -0.38% |
| CAC 40 | 8,049.08 | 41.91 | -0.52% |
| DAX 40 | 22,386.94 | 38.99 | -0.17% |
| Dow JONES (US) | 43,393.43 | 67.78 | -0.16% |
| FTSE 100 | 8,669.81 | 10.83 | 0.13% |
| HKSE | 23,294.37 | 260.35 | 1.13% |
| NASDAQ | 18,937.05 | 349.88 | -1.81% |
| Nikkei 225 | 37,840.44 | 397.35 | -1.04% |
| NZX 50 Index | 12,460.88 | 153.61 | 1.25% |
| S&P 500 | 5,925.78 | 57.47 | -0.96% |
| S&P/ASX 200 | 8,228.30 | 23.60 | -0.29% |
| SSE Composite Index | 3,351.21 | 5.17 | 0.15% |